The present findings indicate that IL10 hyporesponsiveness or “IL10 resistance” occurs in immune cells from humans with T2D and in macrophages cultured in physiologically-relevant hyperglycemia. The gene discussed is IL10; the disease is type 2 diabetes mellitus.